search query: @indexterm PHARMACEUTICAL INDUSTRY / total: 673
references: 14-23 / 673
« previous page | next page »
 titleyearauthor
14.
Demographic change and pharmaceuticals' stock returns
European Financial Management
2011 : SEP, VOL. 17:4, p. 726-754
 2011 Ammann, M.
Berchtold, R.
Seiz, R.
15.
Knowledge-sharing enablers and barriers in pharmaceutical research and development
Journal of Knowledge Management
2011 : VOL. 15:1 p. 53-70
 2011 Lilleoere, A.
Hansen, E.H.
16.
Relationalism in marketing channels and marketing strategy
European Journal of Marketing
2011 : VOL 45:3, p. 311-333
 2011 Paswan, A. K.
Blankson, C.
Guzman, F.
17.
Workplace isolation: salespeople and supervisors in USA
International journal of human resource management
2011 : FEB-MAR, VOL 22:4-6 p. 902-923
 2011 Mulki, J.P.
Jaramillo, F.
18.
When are assets complementary? Star scientists, strategic alliances, and innovation in the pharmaceutical industry
Strategic Management Journal
2011 : AUG, VOL. 32:8, p. 895-909
 2011 Hess, A.M.
Rothaermel, F.T.
19.
Extraordinary pricing of orphan drugs: is it a socially responsible strategy for the U.S. pharmaceutical industry?
Journal of Business Ethics
2010 : JUN III, VOL. 94:2, p. 225-242
 2010 Hemphill, T.A.
20.
Direct-to-consumer advertising of pharmaceuticals as a matter of corporate social responsibility?
Journal of Business Ethics
2010 : JUN III, VOL. 94:2, p. 211-224
 2010 Pol, P.K.C. van de
Bakker, F.G.A. de
21.
Countervailing power in wholesale pharmaceuticals
Journal of Industrial Economics
2010 : MAR, VOL. 58:1, p. 32-53
 2010 Ellison, S.F.
Snyder, C.M.
22.
Benchmarking and transparency: incentives for the pharmaceutical industry’s corporate social responsibility
Journal of Business Ethics
2010 : SEP, VOL. 95:4, p. 641-658
 2010 Lee, M.
Kohler, J.
23.
Leveraging internal and external experience: exploration, exploitation, and R&D project performance
Strategic Management Journal
2010 : JUL, VOL. 31:7, p. 734-758
 2010 Hoang, H.
Rothaermel, F.T.
« previous page | next page »
SCIMA